Immune checkpoint inhibitor–related pancreatitis with fulminant type 1 diabetes mellitus: a case report
Li Niu, Shiqi Sun, Lingyue Zhang, Yanyan Song, Qi Huang, Jiazhong Sun · 2026
Read Immune checkpoint inhibitor–related pancreatitis with fulminant type 1 diabetes mellitus: a case report by Li Niu, Shiqi Sun, Lingyue Zhang, Yanyan Song, Qi Huang, Jiazhong Sun (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13619575.txt.
Description
Li Niu and co-authors report a 2026 case study of a rare, dangerous side effect of cancer immunotherapy. Drugs called immune checkpoint inhibitors free the immune system to attack tumors, but the freed system can also strike healthy organs. The pancreas can suffer inflammation, new diabetes, or both at once.
The patient was a 59-year-old man with tongue cancer treated with one such drug plus chemotherapy. Seven days in, he arrived with nausea, vomiting, and confusion. Tests showed very high blood sugar with severe ketoacidosis, a normal long-term sugar marker, and an inflamed pancreas on scans. His islet function was fully lost, marking a fulminant form of type 1 diabetes. The drug was stopped for good, and he was treated with fluids and fasting.
Catalog record
| CREATOR | Li Niu, Shiqi Sun, Lingyue Zhang, Yanyan Song, Qi Huang, Jiazhong Sun |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |